Product Description

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on April 1, 2008. The length of the article is 485 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose Glyconutrient Products.
Author: Gale Reference Team
Publication: BIOTECH Patent News (Newsletter)
Date: April 1, 2008
Publisher: Biotech Patent News
Volume: 22 Issue: 4

Distributed by Gale, a part of Cengage Learning

---

Product Details

• Amazon Sales Rank: #5632621 in Books
• Published on: 2008-04-01
• Released on: 2008-10-23
• Format: HTML
• Binding: Digital
• 2 pages

Excerpt. © Reprinted by permission. All rights reserved.

Mannatech, Incorporated (Coppell, TX), a leading developer and provider of dietary supplements and skin care solutions, announced that a federal court jury in the Northern District of Texas found that Glycoproducts International Inc. had committed infringement of Mannatech's patent and trademark relating to Ambrotose.

The jury found Glycoproducts International, Inc. had committed patent infringement on Mannatech's United States Patent 7,157,431. The jury found that this infringement was willful, and also ruled in favor of Mannatech on all patent validity issues presented to the jury. In addition, the jury ruled in favor of Mannatech relative to trademark infringement claims made in the case. Based on these rulings, Mannatech will also be pursuing an immediate injunction prohibiting...